Aerie Misses Quick Path To Dry Eye Approval, But Is Still Moving Forward

After Failing Phase IIb Study, Company Adds Phase III Trial

 
• By Joseph Haas
  
Render illustration of Clinical Trial title on medical documents
Disappointing results from a Phase IIb study don't forestall Aerie's plans in dry eye
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D